High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer.

"Declarations Ethics approvalThis study was approved by the ethics committee of the First Affiliated Hospital of Xi’an Jiaotong University (No. XJTU1AF2022LSK-182). Consent to participateAll authors participate in this article. Consent to publishAll authors agree to publish this article. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by the Clinical Research Award of the First Affiliated Hospital of Xi’an Jiaotong University, China (XJTU1AF-2018-017 and XJTU1AF-CRF-2019-002), the Natural Science Basic Research Program of Shaanxi (2018JM7073 and 2017ZDJC-11), the Key Research and Development Program of Shaanxi (2017ZDXM-SF-068 and 2019QYPY-138), the Innovation Capability Support Program of Shaanxi (2017XT-026 and 2018XT-002), and the Medical Research Project of Xi’an Social Development Guidance Plan (2017117SF/YX011-3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, results, and conclusions reported in this article are those of the authors, and are independent from these funding sources."